Production of artificial piRNAs in flies and mice
Abstract
In animals a discrete class of small RNAs, the piwi-interacting RNAs (piRNAs), guard germ cell genomes against the activity of mobile genetic elements. piRNAs are generated, via an unknown mechanism, from apparently single-stranded precursors that arise from discrete genomic loci, termed piRNA clusters. Presently, little is known about the signals that distinguish a locus as a source of piRNAs. It is also unknown how individual piRNAs are selected from long precursor transcripts. To address these questions, we inserted new artificial sequence information into piRNA clusters and introduced these marked clusters as transgenes into heterologous genomic positions in mice and flies. Profiling of piRNA from transgenic animals demonstrated that artificial sequences were incorporated into the piRNA repertoire. Transgenic piRNA clusters are functional in non-native genomic contexts in both mice and flies, indicating that the signals that define piRNA generative loci must lie within the clusters themselves rather than being implicit in their genomic position. Comparison of transgenic animals that carry insertions of the same artificial sequence into different ectopic piRNA-generating loci showed that both local and long-range sequence environments inform the generation of individual piRNAs from precursor transcripts.
Additional Information
© 2012 RNA Society. Published by Cold Spring Harbor Laboratory Press. Received August 8, 2011. Accepted September 26, 2011. Published in Advance November 17, 2011. We thank members of the Hannon and Aravin labs for helpful discussion and comments on the manuscript. We thank members of the McCombie lab (CSHL) and Igor Antoshechkin (Caltech) for help with RNA sequencing. We thank Andres Canela (CSHL) for technical assistance and Simon Knott (CSHL) and Alex Zahn (Caltech) for help with statistical analysis. Sang Yong Kim (CSHL) created the transgenic mice used in this study. F.M. was supported by the Volkswagen Foundation and B.C. by the Boehringer Ingelheim Fonds. This work was supported by grants from the National Institutes of Health (DP2 OD007371A and R00HD057233 to A.A.A.; 5R01GM062534 to G.J.H.), by the Ellison Medical Foundation (A.A.A.), and by a kind gift from Kathryn W. Davis (G.J.H.).Attached Files
Published - Muerdter2012p16789Rna.pdf
Supplemental Material - Muerdter_suppl_figures.pdf
Supplemental Material - Supp_Fig_Legends.docx
Files
Additional details
- PMCID
- PMC3261743
- Eprint ID
- 28982
- Resolver ID
- CaltechAUTHORS:20120126-110548127
- Volkswagen Foundation
- Boehringer Ingelheim Fonds
- NIH
- DP2 OD007371A
- NIH
- R00 HD057233
- NIH
- 5R01GM062534
- Ellison Medical Foundation
- Created
-
2012-01-26Created from EPrint's datestamp field
- Updated
-
2021-11-09Created from EPrint's last_modified field